Buying Above Cost Basis Is the Story
Michael Saylor’s Monday announcement on X — that Strategy (MSTR) added 535 bitcoin last week, paying roughly $43 million at an average of $80,340 per coin — looked routine in size. It wasn’t routine in math. That average sat about $4,800 above the firm’s own cumulative cost basis of $75,540 per BTC. Strategy paid up for these coins.
For a treasury that has built 818,869 BTC at a $61.86 billion all-in spend, buying any new tranche above the running average is unusual mechanics. It tells you the company is no longer dollar-cost-averaging; it is bidding at price. That alone reframes how to read the week’s news.
The “Potential Sales” Quote, in Context
The reason this purchase is being scrutinized is that it followed a very different message only days earlier. On the first-quarter earnings call, management said the firm was prepared to sell bitcoin to repay convertible debt or to fund dividend obligations — provided the move “remains accretive on a bitcoin-per-share basis.”
That phrase is the whole framework. Strategy is not saying it will or won’t sell. It is saying every move — buy or sell — gets tested against one ratio: bitcoin held per outstanding share. If issuing equity to buy BTC raises that ratio, they buy. If selling BTC to retire dilutive obligations raises that ratio, they sell. The 535 BTC tranche was financed by $42.9 million in newly issued common stock, disclosed in a May 11 SEC filing — meaning management ran the math and concluded that the dilution from those shares left holders with more bitcoin per share than they started the week with.
Scale Check Against Recent Buys
Five hundred and thirty-five coins is a small tranche by Strategy’s own history. The April 21 disclosure put a single weekly purchase near 34,000 BTC. Last week’s buy is roughly 1.5% of that pace. The slowdown is consistent with a treasury that is now buying selectively above its cost basis rather than aggressively averaging into weakness.
It also matters that this $43 million came entirely from new equity, not debt. That keeps the accretive test cleaner: the dilution per share is fixed and small, and every coin acquired is unencumbered.
What This Means for Traders
For anyone trading MSTR or BTC on the back of Strategy’s flows, three takeaways stand out.
1. The “potential sales” headline does not signal a treasury liquidation. The accretive-per-share rule constrains sales to scenarios where exiting BTC actually shrinks share count faster than it shrinks the stack. With BTC trading near $81,000 and cost basis at $75,540, the holding is in unrealized profit, but that alone does not trigger a sale. A sale only clears the bar if the proceeds retire enough convertibles or other dilutive instruments to raise BTC-per-share — a much higher hurdle than simple profit-taking.
2. The buying cadence is decelerating, not stopping. Going from 34,000 BTC weekly buys in April to 535 BTC in early May is a meaningful step-down. Traders modeling Strategy as a steady, size-agnostic bid on bitcoin should recalibrate. The bid is now conditional and far smaller.
3. The funding signal lives in the equity issuance, not the BTC purchase. When Strategy raises $42.9 million through at-the-market stock sales and immediately deploys it into BTC, the relevant question for the BTC market is not “did they buy” — it’s “at what premium did the equity clear, and was that premium high enough to be accretive?” When that premium compresses, the buying compresses with it.
Saylor’s 535 BTC purchase three days after floating sale scenarios is not a contradiction. It is the same rule running in two directions: buy when issuance is accretive, sell when reduction is accretive. Both moves serve one number — bitcoin per share — and that number is what traders should watch ahead of any treasury announcement, not the headline action itself.